|
Pulmonology / Original Article
Pleural fluid cytokines in malignant pleural effusion: associations with lung expandability and prediction of pleurodesis outcome
Jarudul Phocharoen, Pimpayao Sodsai, Virissorn Wongsrichanalai, Vorawut Thanthitaweewat, Thitiwat Sriprasart, Nophol Leelayuwatanakul
Korean J Intern Med. 2026;41(6):1104-1113. Published online November 1, 2026
Background/Aims: Lung expandability is a key determinant of successful pleurodesis in malignant pleural effusion (MPE). Although pleural elastance is widely used to assess expandability, pleurodesis may still fail in some patients with low elastance. This study investigated pleural fluid cytokines as..
|
|
|
Nephrology / Original Article
Shen-Kang protects against tacrolimus-induced renal injury
Long Ye Zhang, Jian Jin, Kang Luo, Shang Guo Piao, Hai Lan Zheng, Ji Zhe Jin, Sun Woo Lim, Bum Soon Choi, Chul Woo Yang, Can Li
Korean J Intern Med. 2019;34(5):1078-1090. Published online February 12, 2018
Background/Aims: Evidence suggests that Shen-Kang (SK), a traditional Chinese herbal medicine, protects against various types of renal injury. In this study, we evaluated whether SK treatment confers renoprotection in a rat model of chronic tacrolimus (TAC) nephropathy.
Methods: Rats were treated d..
|
|
|
Pulmonology / Review
Modifiers of TGF-b1 effector function as novel therapeutic targets of pulmonary fibrosis
Chang-Min Lee, Jin Wook Park, Won-Kyung Cho, Yang Zhou, Boram Han, Pyoung Oh Yoon, Jeiwook Chae, Jack A Elias, Chun Geun Lee
Korean J Intern Med. 2014;29(3):281-290. Published online April 29, 2014
Pulmonary fibrosis is a fatal progressive disease with no effective therapy. Transforming growth factor (TGF)-b1 has long been regarded as a central mediator of tissue fibrosis that involves multiple organs including skin, liver, kidney, and lung. Thus, TGF-b1 and its signaling pathways have been at..
|
|
|